Responsible use to responsible harm: illicit drug use and peer harm reduction in a darknet cryptomarket

References

• Abel, G. M., & Fitzgerald, L. J. (2012). ‘The street’s got its advantages’: Movement between sectors of the sex industry in a decriminalised environment. Health, Risk & Society, 14(1), 7–23. doi:10.1080/13698575.2011.640664
   Web of Science ®Google Scholar
• Aldridge, J., & Askew, R. (2017). Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement. International Journal of Drug Policy, 41(Supplement C), 101–109. doi:10.1016/j.drugpo.2016.10.010
   PubMedGoogle Scholar
• Aldridge, J., & Décary-Hétu, D. (2014) “Not an “e-Bay for drugs”: The cryptomarket “silk road” as a paradigm shifting criminal innovation”. SSRN Scholarly Paper, Rochester, NY: Social Science Research Network.
   Google Scholar
• Aldridge, J., & Décary-Hétu, D. (2016). Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets. International Journal of Drug Policy, 35, 7–15. doi:10.1016/j.drugpo.2016.04.020
   PubMed Web of Science ®Google Scholar
• Aldridge, J., Stevens, A., & Barratt, M. J. (2017). Will growth in cryptomarket drug buying increase the harms of illicit drugs? Addiction. early online. doi:10.1111/add.13899
   Google Scholar
• Askew, R. (2016). Functional fun: Legitimising adult recreational drug use. International Journal of Drug Policy, 36, 112–119. doi:10.1016/j.drugpo.2016.04.018
   PubMed Web of Science ®Google Scholar
• Bancroft, A., & Scott Reid, P. (2016). Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. International Journal of Drug Policy, 35, 42–49. doi:10.1016/j.drugpo.2015.11.008
   PubMed Web of Science ®Google Scholar
• Barratt, M. J. (2011) “Discussing illicit drugs in public internet forums: Visibility, stigma, and pseudonymity.” In: Proceedings of the 5th International Conference on Communities and Technologies, Brisbane, pp. 159–168.
   Google Scholar
• Barratt, M. J., Allen, M., & Lenton, S. (2014a). ‘PMA sounds fun’: Negotiating drug discourses online. Substance Use & Misuse, 49(8), 987–998. doi:10.3109/10826084.2013.852584
   PubMed Web of Science ®Google Scholar
• Barratt, M. J., Coney, L., Aldridge, J., et al. (2017). Who initiates drug use through cryptomarkets?. Conference paper presented at The 11th Annual Conference of the International Society for the Study of Drug Policy, Aarhus, Denmark.
   Google Scholar
• Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2014). Use of silk road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction, 109(5), 774–783. doi:10.1111/add.12470
   Google Scholar
• Barratt, M. J., Ferris, J. A., & Winstock, A. R. (2016). Safer scoring? Cryptomarkets, social supply and drug market violence. International Journal of Drug Policy, 35, 24–31. doi:10.1016/j.drugpo.2016.04.019 35
   Google Scholar
• Barratt, M. J., Lenton, S., Maddox, A., and Allen, M. (2016). ‘What if you live on top of a bakery and you like cakes?’ Drug use and harm trajectories before, during and after the emergence of Silk Road. International Journal of Drug Policy, 35, 50–57. doi:10.1016/j.drugpo.2016.04.006
   PubMed Web of Science ®Google Scholar
• Beckert, J., & Dewey, M. (2017). Introduction: The social organization of illegal markets. In J. Beckert & M. Dewey (eds.), The architecture of illegal markets: Towards an economic sociology of illegality in the economy (pp. 1–34). Oxford: Oxford University Press.
   Google Scholar
• Beer, D. (2016). Metric power. London: Palgrave Macmillan.
   Google Scholar
• Boucher, L. M., Marshall, Z., Martin, A., et al. (2017). Expanding conceptualizations of harm reduction: Results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduction Journal, 14, 18. doi:10.1186/s12954-017-0145-2
   PubMed Web of Science ®Google Scholar
• Bourgois, P., & Schonberg, J. (2007). Intimate apartheid: Ethnic dimensions of habitus among homeless heroin injectors. Ethnography, 8(7), 7–31. doi:10.1177/1466138107076109
   PubMedGoogle Scholar
• Broséus, J., Morelato, M., Tahtouh, M., and Roux, C. (2017). Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market. Forensic Science International, 279(Supplement C), 288–301. doi:10.1016/j.forsciint.2017.08.026
   PubMedGoogle Scholar
• Brown, P. (2014). Risk and social theory: The legitimacy of risks and risk as a tool of legitimation. Health, Risk & Society, 16(5), 391–397. doi:10.1080/13698575.2014.937678
   Web of Science ®Google Scholar
• Çalışkan, E., Minárik, T., & Osula, A.-M. (2015). Technical and legal overview of the tor anonymity network. Tallinn: NATO Cooperative Cyber Defence Centre of Excellence.
   Google Scholar
• Coomber, R., Moyle, L., & South, N. (2015). The normalisation of drug supply: The social supply of drugs as the ‘other side’ of the history of normalisation. Drugs: Education, Prevention and Policy, 23(3), 255–263.
   Web of Science ®Google Scholar
• Décary-Hétu, D., & Giommoni, L. (2017). Do police crackdowns disrupt drug cryptomarkets? A longitudinal analysis of the effects of Operation Onymous. Crime, Law and Social Change, 67(1), 55–75. doi:10.1007/s10611-016-9644-4
   Web of Science ®Google Scholar
• Décary-Hétu, D., & Quessy-Doré, O. (2017). Are repeat buyers in cryptomarkets loyal customers? Repeat business between dyads of cryptomarket vendors and users. American Behavioral Scientist, 61(11), 1341–1357. doi:10.1177/0002764217734265
   Web of Science ®Google Scholar
• Decorte, T. (2001). Quality control by cocaine users: Underdeveloped harm reduction strategies. European Addiction Research, 7(4), 161–175. doi:10.1159/000050737
   PubMed Web of Science ®Google Scholar
• Drumm, R. D., McBride, D., Metsch, L., et al. (2005). ‘I’m a health nut!’ street drug users’ accounts of self-care strategies. Journal Of Drug Issues, 35(3), 607–629. doi:10.1177/002204260503500311
   Web of Science ®Google Scholar
• Duxbury, S. W., & Haynie, D. L. (2018). Building them up, breaking them down: Topology, vendor selection patterns, and a digital drug market’s robustness to disruption. Social Networks, 52, 238–250. early online.dux 52 doi:10.1016/j.socnet.2017.09.002
   Google Scholar
• Epstein, S. (1996). Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.
   Google Scholar
• Faulkner-Gurstein, R. (2017). The social logic of naloxone: Peer administration, harm reduction, and the transformation of social policy. Social Science & Medicine, 180, 20–27. doi:10.1016/j.socscimed.2017.03.013
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., de Jong, W., Rossi, D., Touzé, G., Rockwell, R., Des Jariais, DC, and Elovick, R. (2007). Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy, 18(2), 107–117. doi:10.1016/j.drugpo.2006.11.006
   PubMed Web of Science ®Google Scholar
• Gilbert, M., & Dasgupta, N. (2017). Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains. International Journal of Drug Policy, 46, 160–167. doi:10.1016/j.drugpo.2017.05.052
   PubMed Web of Science ®Google Scholar
• Gowan, T., Whetstone, S., & Andic, T. (2012). Addiction, agency, and the politics of self-control: Doing harm reduction in a heroin users’ group”. Social Science & Medicine, 74(8), 1251–1260. doi:10.1016/j.socscimed.2011.11.045
   PubMed Web of Science ®Google Scholar
• Gunter, B., Hansen, A., & Touri, M. (2010). Alcohol advertising and young people’s drinking: Representation, reception and regulation. New York: Palgrave MacMillan.
   Google Scholar
• Harris, M, & Rhodes, T. (2012). Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction, 107(6), 1090–1096. doi:10.1111/add.2012.107.issue-6
   PubMed Web of Science ®Google Scholar
• Harris, M., & Rhodes, T. (2013). Methadone diversion as a protective strategy: The harm reduction potential of ‘generous constraints’. International Journal of Drug Policy, 24(6), e43–e50. doi:10.1016/j.drugpo.2012.10.003
   PubMedGoogle Scholar
• Hunt, G. P., Evans, K., & Kares, F. (2007). Drug use and meanings of risk and pleasure. Journal of Youth Studies, 10(1), 73–96. doi:10.1080/13676260600983668
   Google Scholar
• Jauffret-Roustide, M. (2009). Self-support for drug users in the context of harm reduction policy: A lay expertise defined by drug users’ life skills and citizenship. Health Sociology Review, 18(2), 159–172. doi:10.5172/hesr.18.2.159
   Web of Science ®Google Scholar
• Keane, H. (2003). Critiques of harm reduction, morality and the promise of human rights. International Journal of Drug Policy, 14(3), 227–232. doi:10.1016/S0955-3959(02)00151-2
   Google Scholar
• Lupton, D. (2015). Lively data, social fitness and biovalue: The intersections of health self-tracking and social media. SSRN Scholarly Paper, Rochester, NY: Social Science Research Network.
   Google Scholar
• Lupton, D. (2016). The quantified self: A sociology of self-tracking cultures. Cambridge: Polity.
   Google Scholar
• Maddox, A., Barratt, M. J., Allen, M., et al. (2016). Constructive activism in the dark web: Cryptomarkets and illicit drugs in the digital ‘demimonde’. Information, Communication & Society, 19(1), 111–126. doi:10.1080/1369118X.2015.1093531
   Web of Science ®Google Scholar
• Martin, J. (2014). Drugs on the dark net: How cryptomarkets are transforming the global trade in illicit drugs. London: Palgrave Macmillan.
   Google Scholar
• Measham, F., & Shiner, M. (2009). The legacy of ‘normalisation’: The role of classical and contemporary criminological theory in understanding young people’s drug use. International Journal of Drug Policy, 20(6), 502–508. doi:10.1016/j.drugpo.2009.02.001
   PubMed Web of Science ®Google Scholar
• Moeller K, Munksgaard R and Demant J (2017) Flow My FE the Vendor Said: Exploring Violent and Fraudulent Resource Exchanges on Cryptomarkets for Illicit Drugs. American Behavioral Scientist early online. doi: 10.1177/0002764217734269.
   Google Scholar
• Moore, D. (2008). Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence. International Journal of Drug Policy, 19(5), 353–358. doi:10.1016/j.drugpo.2007.07.004
   PubMed Web of Science ®Google Scholar
• Mounteney, J, Cunningham, A, & Groshkova, T, et al. (2017) Looking to the future—more concern than optimism that cryptomarkets will reduce drug-related harms. Addiction early online. doi:10.1111/add.14056/
   Google Scholar
• Munksgaard, R., Bakken, S., & Demant, J. (2017). Risk perception in emerging markets for illicit substances in Scandinavia: The effect of available information through online communities. Conference paper presented at The Scandinavian Research Council for Criminology, Stockholm, Sweden.
   Google Scholar
• Munksgaard, R., & Demant, J. (2016). Mixing politics and crime–The prevalence and decline of political discourse on the cryptomarket. International Journal of Drug Policy, 35, 77–83. doi:10.1016/j.drugpo.2016.04.021
   PubMed Web of Science ®Google Scholar
• Pasquale, F. (2017). Two narratives of platform capitalism. Yale Law & Policy Review, 35(1), 11.
   Google Scholar
• Pauly, B. (2008). Harm reduction through a social justice lens. International Journal Of Drug Policy, 19(1), 4–10. doi:10.1016/j.drugpo.2007.11.005
   PubMed Web of Science ®Google Scholar
• Pereira, M., & Scott, J. (2017). Harm reduction and the ethics of drug use: Contemporary techniques of self-governance. Health Sociology Review, 26(1), 69–83. doi:10.1080/14461242.2016.1184583
   Web of Science ®Google Scholar
• Rhodes, T. (1997). Risk theory in epidemic times: Sex, drugs and the social organisation of ‘risk behaviour’. Sociology of Health and Illness, 19(2), 208–227. doi:10.1111/shil.1997.19.issue-2
   Web of Science ®Google Scholar
• Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. doi:10.1016/S0955-3959(02)00007-5
   Google Scholar
• Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3), 193–201. doi:10.1016/j.drugpo.2008.10.003
   PubMed Web of Science ®Google Scholar
• Robins, S. (2004). ‘Long live Zackie, long live’: AIDS activism, science and citizenship after apartheid. Journal of Southern African Studies, 30, 651–672. doi:10.1080/0305707042000254146
   Web of Science ®Google Scholar
• Soska, K., & Christin, N. (2015) “Measuring the longitudinal evolution of the online anonymous marketplace ecosystem”. Proceedings of the 22nd USENIX Security Symposium, Washington, DC.
   Google Scholar
• van Buskirk, J., Naicker, S., Roxburgh, A., Bruno, R. and Burns, L. (2016). Who sells what? Country specific differences in substance availability on the Agora cryptomarket. International Journal of Drug Policy, 35, 16–23. doi:10.1016/j.drugpo.2016.07.004
   PubMed Web of Science ®Google Scholar
• van Hout, M. C., & Bingham, T. (2014). Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy, 25(2), 183–189. doi:10.1016/j.drugpo.2013.10.009
   PubMed Web of Science ®Google Scholar
• van Hout, M. C., & Hearne, E. (2016). New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. International Journal of Drug Policy, 40, 102–110. doi:10.1016/j.drugpo.2016.11.007
   PubMed Web of Science ®Google Scholar
• Winstock, A. R., & Barratt, M. J. (2017). Dark-net markets: The good, the bad and ugly?.Blog Post, Global drug survey https://www.globaldrugsurvey.com/gds2017-launch/dark-net-markets-the-good-the-bad-and-ugly/
   Google Scholar
• Zinn, J. O. (2008). Heading into the unknown: Everyday strategies for managing risk and uncertainty. Health, Risk & Society, 10(5), 439–450. doi:10.1080/13698570802380891
   Web of Science ®Google Scholar
• Zinn, J. O. (2015). Towards a better understanding of risk-taking: Key concepts, dimensions and perspectives. Health, Risk & Society, 17(2), 99–114. doi:10.1080/13698575.2015.1023267
   Web of Science ®Google Scholar